U.S. Stock News

S&P Global recently announced that Saugata Saha, President of S&P Global Market Intelligence and Chief Enterprise Data Officer, will depart the company on July 30, 2026, with the Enterprise Data Organization shifting under the Chief Technology & Transformation Office, while the board approved a US$0.97 second-quarter 2026 dividend. These governance and organizational changes arrive as shareholders rejected proposals to ease special-meeting thresholds and expand reporting on discriminatory...

Over recent days, Mastercard has featured in several developments, including a Eurosystem-led pilot for instant cross-currency payments, new crypto-linked card partnerships like KuCoin’s KuCard in Australia, and continued engagement in sustainability forums. Together with analysts spotlighting agentic technology and stablecoins as potential long-term payment drivers, these moves underscore Mastercard’s push to build relevance beyond traditional card rails and into next-generation money...

Houston expansion puts Floor & Decor Holdings (FND) back in focus Floor & Decor Holdings (FND) is expanding again, this time with its 13th Houston area warehouse store and design center in Meyerland. This gives investors another data point on the retailer’s physical growth plans. See our latest analysis for Floor & Decor Holdings. The Meyerland opening comes after a stretch where the stock has been under pressure, with the 3 year total shareholder return down 44.45% and the 1 year total...

Helios Technologies (HLIO) has drawn investor attention after a recent share move, with the stock up around 24% over the past month and roughly 17% over the past 3 months. See our latest analysis for Helios Technologies. At a share price of $83.05, Helios Technologies has enjoyed strong momentum recently, with a 30 day share price return of 24.25% and a year to date share price return of 51.80%, while the 1 year total shareholder return of 190.12% points to powerful compounding over time. If...

Event context and recent price performance NovoCure (NVCR) stock has drawn investor attention after recent trading left the shares at a last close of US$16.56, with the move coming alongside mixed short term and longer term return patterns. The stock declined 2.8% over the past day and 7.8% over the past week, was broadly flat over the past month, and is up about 24.5% over the past 3 months and 26.2% year to date. See our latest analysis for NovoCure. Looking beyond the latest pullback,...

Morningstar (MORN) has drawn fresh attention after reporting a 37% rise in operating income and retiring 10% of its shares, along with segment growth in data platforms and credit ratings despite higher leverage and mixed segment momentum. See our latest analysis for Morningstar. The latest results have coincided with a sharp move in the share price, with a 1-day share price return of 7.58% and a 30-day share price return of 15.85%. This comes even as the year-to-date share price return is...

GameStop Corp. recently asked shareholders to approve a significant amendment to its certificate of incorporation that would raise authorized common stock to 2.50 billion shares, while also quietly lifting its ownership stake in eBay to 7.8% after eBay’s board rejected an earlier buyout approach. Together, the much larger share authorization and the increased eBay stake highlight GameStop’s emphasis on preserving flexibility for sizable corporate actions, including potential acquisitions,...

Recent analyst reports highlight a more positive earnings outlook for AbCellera Biologics (ABCL). This coincides with the stock outperforming the broader Medical sector and its peers this year, which has influenced sentiment around its recent move. See our latest analysis for AbCellera Biologics. The recent 1 month share price return of 45.82% and 90 day share price return of 74.12% suggest momentum has been building, even though the 3 year total shareholder return is slightly down while the...

Eli Lilly (NYSE:LLY) reported landmark Phase 3 results for Retevmo as adjuvant therapy in early-stage RET fusion-positive non-small cell lung cancer. The LIBRETTO-432 trial found an 83% reduction in the risk of disease recurrence or death versus placebo, based on event-free survival. Data were presented at ASCO and published in a leading journal, with global regulatory submissions planned. Eli Lilly, known for its portfolio in oncology and other therapeutic areas, is adding another piece to...

NGL Energy Partners LP recently reported past fourth quarter and full-year 2026 results, with revenue easing to US$949.51 million for the quarter and US$3.16 billion for the year, alongside a shift from net income to net losses. Despite these weaker earnings, the partnership completed a sizeable buyback program totaling 8,698,477 units for about US$49.56 million, signaling continued capital-return efforts even after posting losses. With these disappointing earnings and the contrasting...

Array Digital Infrastructure, Inc. previously declared a special dividend of US$11.00 per Common Share and Series A Common Share, payable on June 25, 2026 to shareholders of record on June 11, 2026. This one-off cash distribution stands out as a material capital allocation move that may influence how investors assess the company’s future cash uses and balance sheet flexibility. We’ll now examine how this sizeable one-time US$11.00 special dividend interacts with Array Digital...

Dolby Laboratories (DLB) recently paired mixed earnings guidance with fresh product traction, as its Dolby Atmos audio format rolled out across Chinese social platform rednote, giving investors a new angle on the stock’s creator economy exposure. See our latest analysis for Dolby Laboratories. Despite the latest Dolby Atmos rollout on rednote and a revenue result that exceeded expectations, the stock has come under pressure. The share price is down 13.39% over 90 days and 11.74% year to date,...

In late May 2026, CVS Health announced past updates to its CVS Caremark commercial formularies, reintroducing Zepbound (tirzepatide) as a preferred GLP-1 option from October 1, 2026, and lifting the new-to-market block on the oral GLP-1 Foundayo (orforglipron) for plans that approve coverage. By broadening access to GLP-1 weight management drugs while emphasizing affordability for plan sponsors, CVS Health is reinforcing its role as a pharmacy benefits manager focused on cost control and...

In its recently reported second quarter, Cabot Corporation posted mixed results, with Reinforcement Materials EBIT falling while Performance Chemicals EBIT increased, and outlined capacity rationalization and cost-reduction plans intended to lower expenses by mid-2027. At the same time, Cabot reaffirmed full-year adjusted EPS guidance and raised its quarterly dividend, underscoring management’s confidence in cash generation despite operational pressures. Next, we’ll examine how Cabot’s...

Freshworks recently launched its AI Agent Studio within Freshservice, introducing a no-code way to build autonomous AI agents and a Model Context Protocol Gateway that connects securely to third-party tools like Workday, Slack, and Microsoft Teams without custom coding. The company also added AI Insights and Experience Level Agreements, aiming to quantify service quality and employee sentiment so IT leaders can fine-tune support operations and after-hours coverage. Next, we’ll examine how...

Ameren stock snapshot after recent moves Ameren (AEE) has drawn fresh attention after recent trading, with the stock closing at $105.09 and recording declines over the past week, month and past 3 months, set against a positive 1 year total return. See our latest analysis for Ameren. Recent trading has been weak, with the share price down over the past week and quarter. However, the 1 year and multi year total shareholder returns remain firmly positive, suggesting earlier optimism is being...

The Morning Bull - US Market Morning Update Tuesday, Jun, 2 2026 US stock futures are pointing slightly higher this morning, with key contracts linked to the S&P 500 and Nasdaq 100 up around 0.2% as investors weigh signs of stronger global manufacturing against rising costs and higher bond yields. Across Europe and parts of Asia, factory scorecards like the Eurozone manufacturing PMI at 51.6 and India’s PMI at 55.0 show production growing, but input prices are climbing and supply chains...

Installed Building Products (IBP) has drawn investor attention after recent share price weakness, with the stock down about 30% over the past month and roughly 38% over the past 3 months. See our latest analysis for Installed Building Products. That recent share price slide, including a 30-day share price return down about 30% and a 90-day share price return down about 38%, contrasts with a 1-year total shareholder return of about 29%. This suggests momentum has cooled after a strong prior...

Chubb Limited recently secured shareholder approval for a 5.2% increase in its annual dividend to US$4.08 per share and authorized a new US$7.50 billion share repurchase program, while also renewing its capital band and filing a US$4.00 billion shelf registration for common shares tied to an ESOP-related offering. Taken together, these moves highlight Chubb’s use of both higher recurring cash returns and flexible capital authorities to reshape its future equity profile. We’ll now examine how...

In late May 2026, Capri Holdings reported fourth quarter sales of US$796 million and a net loss of US$4 million, alongside full-year sales of US$3.47 billion and net income of US$137 million. Over the same period, the company also completed a share repurchase of 4,000,000 shares for US$79 million, reducing its share count by 3.36% and signaling continued capital return to shareholders. We’ll now examine how Capri’s swing to full-year profitability and recent buyback completion may influence...

Piedmont Realty Trust (PDM) has been drawing fresh attention after signing about 240,000 square feet of second quarter leases, with more than 60% from new tenants and activity above historical averages. See our latest analysis for Piedmont Realty Trust. That leasing progress arrives after a mixed price pattern, with the share price roughly flat year to date, but an 11.59% 90 day share price return and a 12.50% 1 year total shareholder return pointing to gradually improving momentum. If this...

Murphy USA stock at a glance Murphy USA (MUSA) is in focus after recent trading left the stock at $515.68, with performance mixed, up over the past 3 years but down over the past month. See our latest analysis for Murphy USA. The recent pullback, including a 13.61% 1 month share price return and a weaker 7 day move, comes after strong momentum, with a 27.22% year to date share price return and 82.86% 3 year total shareholder return. If you are comparing Murphy USA with other opportunities,...

Universal stock moves without a clear single catalyst Universal (UVV) has seen its stock edge up about 4.4% over the past day, even as returns over the past year are down around 11.9%. This contrast is putting recent trading action in focus for investors. See our latest analysis for Universal. The recent 1 day share price return of 4.4% contrasts with a 1 year total shareholder return that is down about 11.9%. This suggests short term momentum is improving, while longer term performance has...

Fluor Corporation recently announced that its JGC Fluor BC LNG II joint venture received a limited notice to proceed for the proposed Phase 2 expansion of the LNG Canada export facility in Kitimat, British Columbia, following the partners’ delivery of Phase 1 in 2025. This limited notice, combined with Fluor’s quarter featuring US$2.70 billion of mostly reimbursable new awards and backlog rising to US$25.70 billion, underscores how large liquefied natural gas and infrastructure projects...